Issues related to implementing a smoking cessation clinical trial for cancer patients
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Given high rates of smoking among cancer patients, smoking cessation treatment is crucial; yet limited data exist to guide integration of such trials into the oncologic context. In order to determine the feasibility of conducting smoking cessation clinical trials with cancer patients, screening and baseline data from a large randomized placebo-controlled pharmacotherapy trial were analyzed. Descriptive statistics and regression analyses were used to compare enrollees to decliners, describe program enrollees, and assess correlates of confidence in quitting smoking. Out of 14,514 screened patients, 263 (<2%) were eligible; 43 (16%) refused enrollment. Among the eligible patients, 220 (84%) enrolled. Enrollment barriers included smoking rate, medical history/contraindicated medication, lack of interest, and language. Compared to enrollees, decliners were more likely to have advanced cancer. The trial enrolled a sample of 67 (>30%) African Americans; participants had extensive smoking histories; many were highly nicotine dependent; and participants consumed about seven alcoholic beverages/week on average. Head and neck and breast cancer were the most common tumors. About 52 (25%) reported depressive symptoms. A higher level of confidence to quit smoking was related to lower depression and lower tumor stage. Integrating a smoking cessation clinical trial into the oncologic setting is challenging, yet feasible. Recruitment strategies are needed for patients with advanced disease and specific cancers. Once enrolled, addressing participant’s depressive symptoms is critical for promoting cessation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
Khantzian, E. J. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709030550 · Cited by 3,242 · cited 1×
“Based on the self-medication theory of nicotine dependence [18], smoking may continue or patients may relapse to alleviate depressive symptoms.”
First lapses to smoking: Within-subjects analysis of real-time reports.
Shiffman, S., Paty, J. A., Gnys, M., Kassel, J. A., & Hickcox, M. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.2.366 · Cited by 745
Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer
Browman, G. P., Wong, G., Hodson, I., Sathya, J., Russell, R., McAlpine, L., Skingley, P., & Levine, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280302 · Cited by 600 · cited 1×
“time[4], increase risk of developing a second primary tumor [5], reduce the effectiveness of medical treatments [6-11] and diminish patient quality of life by increasing treatment-related complications and side effects [12].”
Investigation of mechanisms linking depressed mood to nicotine dependence
Lerman, C., Audrain, J., Orleans, C. T., Boyd, R., Gold, K., Main, D., & Caporaso, N. (1996) · Addictive Behaviors · doi:10.1016/0306-4603(95)00032-1 · Cited by 209 · cited 1×
“associated with level of nicotine dependence, has been shown to be a mediator between depression and smoking, and has been shown to be related to response to pharmacotherapies for nicotine dependence [24-26].”
Lerman, C., Caporaso, N., Main, D., Audrain, J., Boyd, N. R., Bowman, E. D., & Shields, P. G. (1998) · Health Psychology · doi:10.1037//0278-6133.17.1.56 · Cited by 198
Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer
Walker, M. S., Vidrine, D. J., Gritz, E. R., Larsen, R. J., Yan, Y., Govindan, R., & Fisher, E. B. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0509 · Cited by 147 · cited 1×
“Although tobacco use is widely known as a primary cause of cancer, about 30% of cancer patients who smoked prior to their diagnosis continue to smoke [1], and relapse rates among cancer patients are high [2, 3].”
Cited by
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Antidepressants for smoking cessation
Hughes, J. R., Stead, L. F., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub4 · Cited by 348
Smoking cessation, version 1.2016, NCCN clinical practice guidelines in oncology
Shields, P. G., Herbst, R. S., Arenberg, D., Benowitz, N. L., Bierut, L., Luckart, J. B., Cinciripini, P., Collins, B., David, S., Davis, J., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0152 · Cited by 146
Antidepressants for smoking cessation
Hajizadeh, A., Howes, S., Theodoulou, A., Klemperer, E., Hartmann-Boyce, J., Livingstone-Banks, J., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub6 · Cited by 84
Smartphone health apps for tobacco cessation: a systematic review
Chu, K.-H., Matheny, S. J., Escobar-Viera, C. G., Wessel, C., Notier, A. E., & Davis, E. M. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106616 · Cited by 43
“, cessation counselors) and smokers (Martinez et al., 2018).”
Background
Metadata
- Authors
- Martinez, E., Tatum, K. L., Weber, D. M., Kuzla, N., Pendley, A., Campbell, K., Ridge, J. A., Langer, C., Miyamoto, C., & Schnoll, R. A.
- Venue
- Cancer Causes & Control
- Published
- 2008-08-29
- Volume
- 20
- Issue
- 1
- Pages
- 97-104
- ISSN
- 0957-5243 (ISSN-L)
- 1573-7225
- OpenAlex
- W2038961232
- Cited by
- 47
- References
- 6
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Issues related to implementing a smoking cessation clinical trial for cancer patients. https://app.cochat.ai/papers/10.1007/s10552-008-9222-x
- The paper
- Martinez, E., Tatum, K. L., Weber, D. M., Kuzla, N., Pendley, A., Campbell, K., Ridge, J. A., Langer, C., Miyamoto, C., & Schnoll, R. A. (2009). Issues related to implementing a smoking cessation clinical trial for cancer patients. Cancer Causes & Control. https://doi.org/10.1007/s10552-008-9222-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.